Compare Fluence Energy Inc. Class A Common Stock (FLNC) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fluence Energy Inc. Class A Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Fluence Energy Inc. Class A Common Stock trades at $6.11 (market cap $969.93M), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 11.1× Fluence Energy Inc. Class A Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Fluence Energy Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fluence Energy Inc. Class A Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| FLNC | RDY | |
|---|---|---|
Market Cap | $969.93M | $10.78B |
Volume | 7,001,648 | 2,724,343 |
Sector | Utilities | Health |
52-Week High | $32.23 | $15.38 |
52-Week Low | $6.21 | $11.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.02B | $10.68B |
Dividend Yield | — | 0.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fluence Energy Inc. Class A Common Stock
Fluence Energy Inc. designs and delivers energy storage products, operational services, and asset optimization software for renewable-energy and storage applications worldwide.
Read more on FLNC →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
